跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Epicraine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Epicraine
Approved
STANDARD
Epicraine
Jayson Pharmaceuticals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fc495281c56f889d
Company
Jayson Pharmaceuticals Ltd.
Type
Standard
Approval Details
Approval Id
fc495281c56f889d
Drug Approval Philippines Name
Epicraine
Product Name
Epicraine
Registration Number
DRP-7802-01
Brand Name
Epicraine
Generic Name
Lidocaine Hydrochloride + Epinephrine (As Bitartrate)
Dosage Form
Solution For Injection (Local Infiltration)
Dosage Strength
20 mg/12.5 mcg per mL
Manufacturer
Jayson Pharmaceuticals Ltd.
Importer
Aglobal Care Inc.
Distributor
Bellus Life Solutions, Inc.
Issuance Date
27 May 2021
Expiry Date
26 April 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fc495281c56f889d
Type
Standard
Back to Philippines FDA Approvals